Home » Topics » Disease categories and therapies » Immune

Immune
RSS

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Aviron's EBV vaccine completes phase I trial

Aug. 13, 1999

Aquila Biopharmaceuticals receives SBIR grant for CD1 tuberculosis vaccine

Aug. 13, 1999

Viron Therapeutics awarded US patent for use of viral proteins as antiinflammatory agents

Aug. 6, 1999

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

Aug. 5, 1999

SB and Finlay Institute of Cuba enter agreement for bacterial meningitis vaccine

Aug. 3, 1999

Mutual recognition granted to Agrippal; vaccine to be marketed throughout Europe

Aug. 2, 1999

Aviron and Medeva extend FluMist collaboration

Aug. 2, 1999

Cangene product for prevention of hemolytic disease approved in U.K.

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...